Caplight Directory>Investors>Medfine Capital>Medfine-capital


Medfine Capital

Medfine Capital

Shanghai, Shanghaimedfinecapital.com

Overview

Medfine Capital is a venture capital firm that focuses on investing in early-stage and fast-growth stage companies within the life sciences and healthcare sectors . They seek to invest in areas such as biotechnology, healthcare IT, medical technologies, and pharmaceuticals .

Year Founded

2014

Portfolio Companies

4

Investments

CompanyDateStageLead
Excalipoint TherapeuticsMar 2026SeedCo-investor
Phrontline BiopharmaNov 2025pre_series_a_plusCo-investor
Excalipoint TherapeuticsAug 2025SeedCo-investor
The Pharma LetterJun 2022Series ALead
AlebundMay 2021Series B-

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2014

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.